Sienna Biopharma Loses Face; Shares Plunge Over 20% As Acne Trials Flop

Shares of Sienna Biopharmaceuticals Inc. (SNNA) are down over 20% in pre-market trading on Monday, following the failure of two of its pivotal acne trials with SNA-001.

from RTT - Biotech https://ift.tt/2LPJZfW
via IFTTT